Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitafloxacin vs levofloxacin in acute mild-to-moderate respiratory and urinary infections
CTR20150320Phase 2Active
- Sponsor
- Judeyangguang Pharmaceutical
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sitafloxacin in upper respiratory infection (URI), Acute bacterial lower respiratory tract infection (ABLRTI), Acute Bacterial Urinary Tract Infection (UTI), sponsored by Judeyangguang Pharmaceutical. Started May 2015; status: active.
02
Drugs
sitafloxacin
03
Conditions
upper respiratory infection (URI)Acute bacterial lower respiratory tract infection (ABLRTI)Acute Bacterial Urinary Tract Infection (UTI)
Beyond the preview
Go deeper on CTR20150320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150320.